Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients

被引:70
|
作者
Lentine, Krista L. [1 ,2 ]
Axelrod, David [3 ]
Klein, Christina [4 ]
Simpkins, Christopher [3 ]
Xiao, Huiling [1 ]
Schnitzler, Mark A. [1 ,2 ]
Tuttle-Newhall, Janet E. [2 ]
Dharnidharka, Vikas R. [4 ]
Brennan, Daniel C. [4 ]
Segev, Dorry L. [5 ]
机构
[1] St Louis Univ, Ctr Outcomes Res, Sch Med, St Louis, MO 63104 USA
[2] St Louis Univ, Sch Med, Dept Surg, Div Abdominal Transplantat, St Louis, MO 63104 USA
[3] Dartmouth Hitchcock Med Ctr, Dept Surg, Div Abdominal Transplantat, Hanover, NH USA
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] Johns Hopkins Univ, Dept Surg, Div Abdominal Transplantat, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
Blood group incompatibility; Hemorrhage; Infection; Kidney transplantation; Living donors; Medicare; ANTIGEN-SPECIFIC IMMUNOADSORPTION; RENAL-TRANSPLANTATION; UNITED-STATES; COAGULATION ABNORMALITIES; PAIRED DONATION; ACUTE REJECTION; GRAFT FAILURE; SPLENECTOMY; PLASMAPHERESIS; RITUXIMAB;
D O I
10.1097/TP.0000000000000029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Descriptions of the sequelae of ABO-incompatible (ABOi) kidney transplantation are limited to single-center reports, which may lack power to detect important effects. Methods. We examined U. S. Renal Data System registry data to study associations of ABOi live-donor kidney transplantation with clinical complications in a national cohort. Among 14,041 Medicare-insured transplants in 2000 to 2007, 119 non-donor-A2 ABOi transplants were identified. A2-incompatible (n=35) transplants were categorized separately. Infection and hemorrhage events were identified by diagnosis codes on billing claims. Associations of ABO incompatibility with complications were assessed by multivariate Cox regression. Results. Recipients of ABOi transplants experienced significantly (P<0.05) higher incidence of wound infections (12.7% vs. 7.3%), pneumonia (7.6% vs. 3.8%), and urinary tract infections (UTIs) or pyelonephritis (24.5% vs. 15.3%) in the first 90 days compared with ABO-compatible recipients. In adjusted models, ABO incompatibility was associated with twice the risk of pneumonia (adjusted hazard ratio [aHR], 2.22; 95% confidence interval [CI], 1.14-4.33) and 56% higher risk of UTIs or pyelonephritis (aHR, 1.56; 95% CI, 1.05-2.30) in the first 90 posttransplantation days, and 3.5 times the relative risk of wound infections in days 91 to 365 (aHR, 3.55; 95% CI, 1.92-6.57). ABOi recipients, 19% of whom underwent pre- or peritransplant splenectomy, experienced twice the adjusted risk of early hemorrhage (aHR, 1.96; 95% CI, 1.19-3.24). A2-incompatible transplantation was associated only with early risk of UTIs or pyelonephritis. Conclusion. ABOi transplantation offers patients with potential live donors an additional transplant option but with higher risks of infectious and hemorrhagic complications. Awareness of these complications may help improve protocols for the management of ABOi transplantation.
引用
收藏
页码:54 / 65
页数:12
相关论文
共 27 条
  • [21] Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study
    Hirzel, Cedric
    Projer, Lea
    Atkinson, Andrew
    Surial, Bernard
    Mueller, Nicolas J.
    Manuel, Oriol
    Mombelli, Matteo
    van Delden, Christian
    Hirsch, Hans H.
    Boggian, Katia
    Walti, Laura N.
    Sidler, Daniel
    Hadaya, Karine
    Dickenmann, Michael
    Muller, Thomas F.
    Binet, Isabelle
    Golshayan, Dela
    Huynh-Do, Uyen
    TRANSPLANTATION, 2022, 106 (09) : 1875 - 1883
  • [22] Early hospital readmissions after ABO- or HLA-incompatible living donor kidney transplantation
    Lee, Juhan
    Kim, Deok Gie
    Kim, Beom Seok
    Kim, Myoung Soo
    Kim, Soon Il
    Kim, Yu Seun
    Huh, Kyu Ha
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single-center Japanese cohort study
    Kakuta, Yoichi
    Okumi, Masayoshi
    Unagami, Kohei
    Iizuka, Junpei
    Takagi, Toshio
    Ishida, Hideki
    Tanabe, Kazunari
    CLINICAL TRANSPLANTATION, 2019, 33 (06)
  • [24] Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation
    Kota Takahashi
    Kazuhide Saito
    Shiro Takahara
    Shohei Fuchinoue
    Takashi Yagisawa
    Atsushi Aikawa
    Yoshihiko Watarai
    Norio Yoshimura
    Kazunari Tanabe
    Kunio Morozumi
    Motohide Shimazu
    Clinical and Experimental Nephrology, 2017, 21 : 705 - 713
  • [25] Association and prognostic impact of persistent left ventricular hypertrophy after live-donor kidney transplantation: a prospective study
    Sheashaa, Hussein Attia
    Abbas, Tarek M.
    Hassan, Nabil A.
    Mahmoud, Khaled M.
    El-Agroudy, Amgad E.
    Sobh, Mohamed A.
    Ghoneim, Mohamed A.
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2010, 14 (01) : 68 - 74
  • [26] Low Titers of Antidonor ABO Antibodies After ABO-Incompatible Living Donor Liver Transplantation: A Long-Term Follow-Up Study
    Ueda, Daisuke
    Yoshizawa, Atsushi
    Kaneshiro, Masakatsu
    Hirata, Yoshihiro
    Yagi, Shintaro
    Hata, Koichiro
    Okajima, Hideaki
    Egawa, Hiroto
    Uemoto, Shinji
    TRANSPLANTATION DIRECT, 2019, 5 (01):
  • [27] Association and prognostic impact of persistent left ventricular hypertrophy after live-donor kidney transplantation: a prospective study
    Hussein Attia Sheashaa
    Tarek M. Abbas
    Nabil A. Hassan
    Khaled M. Mahmoud
    Amgad E. El-Agroudy
    Mohamed A. Sobh
    Mohamed A. Ghoneim
    Clinical and Experimental Nephrology, 2010, 14 : 68 - 74